Selected References
These references are in PubMed. This may not be the complete list of references from this article.
Alberts D. S., Chang S. Y., Chen H. S., Larcom B. J., Jones S. E. Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. Cancer Treat Rev. 1979 Jun;6 (Suppl):9–17. doi: 10.1016/s0305-7372(79)80005-5.
Alberts D. S., Chen H. S., Mayersohn M., Perrier D., Moon T. E., Gross J. F. Bleomycin pharmacokinetics in man. II. Intracavitary administration. Cancer Chemother Pharmacol. 1979;2(2):127–132. doi: 10.1007/BF00254085.
Alberts D. S., Samon S. E., Chen H. S., Surwit E. A., Soehnlen B., Young L., Moon T. E. In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet. 1980 Aug 16;2(8190):340–342. doi: 10.1016/s0140-6736(80)90340-2.
Allen R. C., Stjernholm R. L., Steele R. H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun. 1972 May 26;47(4):679–684. doi: 10.1016/0006-291x(72)90545-1.
BURCHENAL J. H., KARNOFSKY D. A., MYERS W. P. L. The hepatotoxic action of N-methylformamide in man. Cancer. 1956 Sep-Oct;9(5):949–954. doi: 10.1002/1097-0142(195609/10)9:5<949::aid-cncr2820090514>3.0.co;2-k.
Barlow J. J., Piver M. S. Single agent vs combination chemotherapy in the treatment of ovarian cancer. Obstet Gynecol. 1977 May;49(5):609–611.
Berry R. J., Laing A. H., Wells J. Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. Br J Cancer. 1975 Feb;31(2):218–227. doi: 10.1038/bjc.1975.28.
Bischoff K. B., Dedrick R. L., Zaharko D. S., Longstreth J. A. Methotrexate pharmacokinetics. J Pharm Sci. 1971 Aug;60(8):1128–1133. doi: 10.1002/jps.2600600803.
Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666.
Chu Y. H., Craig A. W., O'Connor P. J. Repair of O6-methylguanine in rat liver DNA is enhanced by pretreatment with single or multiple doses of aflatoxin B1. Br J Cancer. 1981 Jun;43(6):850–855. doi: 10.1038/bjc.1981.124.
Cobb L. M., Connors T. A., Elson L. A., Khan A. H., Mitchley B. C., Ross W. C., Whisson M. E. 2,4-dinitro-5-ethyleneiminobenzamide (CB 1954): a potent and selective inhibitor of the growth of the Walker carcinoma 256. Biochem Pharmacol. 1969 Jun;18(6):1519–1527. doi: 10.1016/0006-2952(69)90267-6.
Coffey J. J., White C. A., Lesk A. B., Rogers W. I., Serpick A. A. Effect of allopurinol on the pharmacokinetics of 6-mercaptopurine (NSC 755) in cancer patients. Cancer Res. 1972 Jun;32(6):1283–1289.
Connors T. A., Cox P. J., Farmer P. B., Foster A. B., Jarman M. Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide. Biochem Pharmacol. 1974 Jan 1;23(1):115–129. doi: 10.1016/0006-2952(74)90318-9.
Cumber A. J., Ross W. C. Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility. Chem Biol Interact. 1977 Jun;17(3):349–357. doi: 10.1016/0009-2797(77)90097-7.
Currie G. A., Basham C. Serum mediated inhibition of the immunological reactions of the patient to his own tumour: a possible role for circulating antigen. Br J Cancer. 1972 Dec;26(6):427–438. doi: 10.1038/bjc.1972.59.
Dedrick R. L., Forrester D. D., Ho D. H. In vitro-in vivo correlation of drug metabolism--deamination of 1- -D-arabinofuranosylcytosine. Biochem Pharmacol. 1972 Jan;21(1):1–16. doi: 10.1016/0006-2952(72)90245-6.
Dendy P. P., Bozman G., Wheeler T. K. In-vitro screening test for human malignant tumours before chemotherapy. Lancet. 1970 Jul 11;1(7663):68–72. doi: 10.1016/s0140-6736(70)92640-1.
Edwards P. A., Easty D. M., Foster C. S. Selective culture of epithelioid cells from a human squamous carcinoma using a monoclonal antibody to kill fibroblasts. Cell Biol Int Rep. 1980 Oct;4(10):917–922. doi: 10.1016/0309-1651(80)90193-9.
Finj C., Sadée W. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):279–286.
Freshney R. I., Paul J., Kane I. M. Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. Br J Cancer. 1975 Jan;31(1):89–99. doi: 10.1038/bjc.1975.11.
Galasko C. S., Sylvester B. S. Back pain in patients treated for malignant tumours. Clin Oncol. 1978 Sep;4(3):273–283.
Harris J. R., Timberlake N., Henson P., Schimke P., Belli J. A. Adriamycin uptake in V79 and adriamycin resistant Chinese hamster cells. Int J Radiat Oncol Biol Phys. 1979 Aug;5(8):1235–1239. doi: 10.1016/0360-3016(79)90645-x.
Harris P. A., Gross J. F. Preliminary pharmacokinetic model for adriamycin (NSC-123127). Cancer Chemother Rep. 1975 Jul-Aug;59(4):819–825.
Heyderman E., Neville A. M. A shorter immunoperoxidase technique for the demonstration of carcinoembryonic antigen and other cell products. J Clin Pathol. 1977 Feb;30(2):138–140. doi: 10.1136/jcp.30.2.138.
Holmes H. L., Little J. M. Tissue-culture microtest for predicting response of human cancer to chemotherapy. Lancet. 1974 Oct 26;2(7887):985–987. doi: 10.1016/s0140-6736(74)92075-3.
Huber P. R., Geyer E., Küng W., Matter A., Torhorst J., Eppenberger U. Retinoic acid-binding protein in human breast cancer and dysplasia. J Natl Cancer Inst. 1978 Dec;61(6):1375–1378.
Ioachim H. L., Sabbath M., Andersson B., Barber H. R. Tissue cultures of ovarian carcinomas. Lab Invest. 1974 Oct;31(4):381–390.
Kinsella A. R., Radman M. Tumor promoter induces sister chromatid exchanges: relevance to mechanisms of carcinogenesis. Proc Natl Acad Sci U S A. 1978 Dec;75(12):6149–6153. doi: 10.1073/pnas.75.12.6149.
Lieberman A., LeBrun Y., Glass P., Goodgold A., Lux W., Wise A., Ransohoff J. Use of high dose corticosteroids in patients with inoperable brain tumours. J Neurol Neurosurg Psychiatry. 1977 Jul;40(7):678–682. doi: 10.1136/jnnp.40.7.678.
Limburg H., Heckmann U. Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. J Obstet Gynaecol Br Commonw. 1968 Dec;75(12):1246–1255. doi: 10.1111/j.1471-0528.1968.tb02931.x.
Malkasian G. D., Jr, Decker D. G., Jorgensen E. O., Edmonson J. H. Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. Cancer Treat Rep. 1977 Aug;61(5):913–914.
Meares A. Meditation: a psychological approach to cancer treatment. Practitioner. 1979 Jan;222(1327):119–122.
Millar J. L., McElwain T. J. Combinations of cytotoxic agents that have less than expected toxicity on normal tissues in mice. Antibiot Chemother (1971) 1978;23:271–282. doi: 10.1159/000401490.
Olin G. R., Ahlbom A. The cancer mortality among Swedish chemists graduated during three decades. A comparison with the general population and with a cohort of architects. Environ Res. 1980 Jun;22(1):154–161. doi: 10.1016/0013-9351(80)90127-9.
Olson R. D., MacDonald J. S., vanBoxtel C. J., Boerth R. C., Harbison R. D., Slonim A. E., Freeman R. W., Oates J. A. Regulatory role of glutathione and soluble sulfhydryl groups in the toxicity of adriamycin. J Pharmacol Exp Ther. 1980 Nov;215(2):450–454.
Owellen R. J., Hartke C. A., Hains F. O. Pharmacokinetics and metabolism of vinblastine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2597–2602.
Owellen R. J., Root M. A., Hains F. O. Pharmacokinetics of vindesine and vincristine in humans. Cancer Res. 1977 Aug;37(8 Pt 1):2603–2607.
Palan P. R., Romney S. L. Cellular binding proteins for vitamin A in human carcinomas and in normal tissues. Cancer Res. 1980 Nov;40(11):4221–4224.
Patton T. F., Himmelstein K. J., Belt R., Bannister S. J., Sternson L. A., Repta A. J. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep. 1978 Sep;62(9):1359–1362.
Pegg A. E., Hui G. Formation and subsequent removal of O6-methylguanine from deoxyribonucleic acid in rat liver and kidney after small doses of dimethylnitrosamine. Biochem J. 1978 Sep 1;173(3):739–748. doi: 10.1042/bj1730739.
Rutty C. J., Connors T. A. In vitro studies with hexamethylmelamine. Biochem Pharmacol. 1977 Dec 15;26(24):2385–2391. doi: 10.1016/0006-2952(77)90446-4.
Rutty C. J., Connors T. A., Nguyen-Hoang-Nam, Do-Cao-Thang, Hoellinger H. In vivo studies with hexamethylmelamine. Eur J Cancer. 1978 Jun;14(6):713–720. doi: 10.1016/0014-2964(78)90308-0.
Saleh A. M., Pheasant A. E., Blair J. A., Allan R. N. The effect of malignant disease on the metabolism of pteroylglutamic acid in man. Biochem Soc Trans. 1980 Oct;8(5):566–567. doi: 10.1042/bst0080566.
Schabel F. M., Jr, Trader M. W., Laster W. R., Jr, Wheeler G. P., Witt M. H. Patterns of resistance and therapeutic synergism among alkylating agents. Antibiot Chemother (1971) 1978;23:200–215. doi: 10.1159/000401484.
Shorthouse A. J., Smyth J. F., Steel G. G., Ellison M., Mills J., Peckham M. J. The human tumour xenograft--a valid model in experimental chemotherapy? Br J Surg. 1980 Oct;67(10):715–722. doi: 10.1002/bjs.1800671011.
Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504.
Tattersall M. H., Sodergren J. E., Dengupta S. K., Trites D. H., Modest E. J., Frei E., 3rd Pharmacokinetics of actinoymcin D in patients with malignant melanoma. Clin Pharmacol Ther. 1975 Jun;17(6):701–708. doi: 10.1002/cpt1975176701.
Theologides A. Cancer cachexia. Cancer. 1979 May;43(5 Suppl):2004–2012. doi: 10.1002/1097-0142(197905)43:5+<2004::aid-cncr2820430708>3.0.co;2-#.
Tisdale M. J. Effect of methionine replacement by homocysteine on the growth of cells. Cell Biol Int Rep. 1980 Jun;4(6):563–570. doi: 10.1016/0309-1651(80)90022-3.
WRIGHT J. C., COBB J. P., GUMPORT S. L., GOLOMB F. M., SAFADI D. Investigation of the relation between clinical and tissue-culture response to chemotherapeutic agents on human cancer. N Engl J Med. 1957 Dec 19;257(25):1207–1211. doi: 10.1056/NEJM195712192572502.
Weibel E. R. Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol. 1969;26:235–302. doi: 10.1016/s0074-7696(08)61637-x.
Wheeler T. K., Dendy P. P., Dawson A. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Oncology. 1974;30(5):362–376. doi: 10.1159/000224977.
Whiting B., Miller S. H., Caddy B. A procedure for monitoring cyclophosphamide and isophosphamide in biological samples. Br J Clin Pharmacol. 1978 Oct;6(4):373–376. doi: 10.1111/j.1365-2125.1978.tb00869.x.